Health Health

EMcision Limited in its sale to Boston Scientific Corporation

On March 5, 2018, Boston Scientific Corporation, one of the world’s premier medical devices companies, acquired EMcision Limited, a privately-held, top-tier medical device company based in the UK and operating throughout the US.   The acquisition will significantly expand Boston...

Lead Office: Montreal Date Closed: March 5, 2018 Value: -

Dialogue Technologies Inc. in its $12 million Series A Financing

On February 13, 2018, Dialogue Technologies Inc. ("Dialogue") announced the closure of a of a Series A funding round of $12-million as it continues to demonstrate significant client growth and widening geographical reach. Dialogue is a Montréal-based virtual health provider that offers...

Lead Office: Montreal Date Closed: February 13, 2018 Value: $12 million

AltaCorp Capital Inc., financial advisor to CanniMed Therapeutics in connection with the acquisition by Aurora Cannabis Inc.

On January 24, 2018, Aurora Cannabis Inc. (“Aurora”) announced it has entered into a support agreement whereby Aurora will acquire all of the issued and outstanding shares of CanniMed Therapeutics Inc. (“CanniMed”) not owned by Aurora. The total consideration for...

Lead Office: Toronto Date Closed: January 24, 2018 Value: $1.1 billion

Acasti Pharma Inc. in its Over-Allotment Option for its Public Offering of Common Shares

On December 27, 2017, Acasti Pharma Inc. (“Acasti”) completed its underwritten public offering of 9,900,990 common shares together with accompanying warrants to purchase an aggregate of 9,802,935 common shares at a combined price to the public of US$1.01 per share and accompanying...

Lead Office: Montreal Date Closed: January 22, 2018 Value: US$11 million

Imagia Cybernetics Inc. in its acquisition of Cadens Medical Imaging

On November 15, 2017, Imagia Cybernetics Inc. (“Imagia”) announced the completion of its acquisition of Cadens Medical Imaging (“Cadens”). This strategic transaction will significantly accelerate Imagia’s mission of delivering accessible personalized healthcare...

Lead Office: Montreal Date Closed: November 15, 2017 Value: -

Deep Genomics in its US$13 million Series A financing

On September 25, 2017, Deep Genomics announced its Series A financing round of approximately US$13 million. The round was led by the U.S. venture capital firm Khosla Ventures, and was joined by True Ventures, which led Deep Genomics’ US$5 million seed financing in 2015. Deep Genomics is a...

Lead Office: Toronto Date Closed: September 25, 2017 Value: US$13 million

Fusion Pharmaceuticals Closes an Oversubscribed US$46 Million Series A Financing

On September 25, 2017, Fusion announced the second closing of its oversubscribed Series A financing, bringing the total capital raised for the current Series A round to US$46 million. Each of Adams Street Partners, Seroba Life Sciences and Varian Medical Systems Inc. participated in the...

Lead Office: Toronto Date Closed: September 25, 2017 Value: US$46 Million

Right-Health in its acquisition of Akira Medical

On September 19, 2017, Right-Health announced the acquisition of Akira Medical. Right-Health will continue to operate the Akira platform under its original name, while founders Dustin Walper, Taha Bandukwala and Matt Zukowski will join Right Health in leadership positions. The Akira team...

Lead Office: Toronto Date Closed: September 19, 2017 Value: -

Stryker Corporation in its acquisition of NOVADAQ Technologies Inc.

On September 1, 2017, Stryker Corporation completed the acquisition of NOVADAQ Technologies Inc. for US$701 million. NOVADAQ'S innovative fluorescence imaging technology will expand Stryker’s product offerings into open and plastic reconstructive surgery. Stryker Corporation is one of the...

Lead Office: Toronto Date Closed: September 1, 2017 Value: US$701 million

Underwriters in connection with the $345 million IPO of Jamieson Wellness on the TSX

On July 7, 2017, Jamieson Wellness announced the completion of its initial public offering of common shares on the Toronto Stock Exchange for $345 million, at a price of $15.75 per share. Jamieson Wellness is Canada’s leading branded manufacturer, distributor and marketer of high quality natural...

Lead Office: Toronto Date Closed: July 7, 2017 Value: $345 million